Novonesis has raised its guidance for the whole of 2026, after dairy and Food & Beverages were among the strongest growth areas in the second quarter, Danish business daily Børsen reports.

Novonesis, which supplies enzymes, cultures and other biosolutions to the dairy industry among others, closed the second quarter with organic growth of 9 per cent and has now raised its guidance for full-year 2026 from 5-7 to 7-8 per cent organic growth. Børsen reported this on Thursday in a review of the group’s half-year results.

According to the newspaper, both of the group’s main divisions contributed to the growth, but the increase was particularly marked within Food & Beverages, which includes dairy, and which grew 11 per cent overall. Novonesis’ dairy business is seeing rising demand for solutions for protein-rich, fresh dairy products, as well as growth within cheese, Børsen reports.

CFO Rainer Lehmann points to the broad-based growth in the results and highlights dairy as one of the areas where the group is currently seeing the strongest momentum:

“We are seeing strong momentum, particularly within dairy and Food & Beverages, and on the other hand within bioenergy and household care,” he told Børsen.

Novonesis’ EBITDA margin is expected to land at the high end of the 37-38 per cent range for the year, after the margin reached 37.6 per cent in the second quarter, up from 36.4 per cent in the same quarter last year.

By Maja Løvstrup
Source: Børsen
Photo: Novonesis